BOSTON & LONDON--(BUSINESS WIRE)--Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in ...
Signifier is the developer of the revolutionary eXcite OSA® medical device for the treatment of sleep disordered breathing, which has now been launched in key markets including the United States of ...
Frequent snoring can be a red flag for mild obstructive sleep apnea (OSA), a commonly undiagnosed condition. The eXciteOSA device is an FDA-authorized daytime therapy designed to strengthen tongue ...
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. CMS establishes new Level II HCPCS codes to describe eXciteOSA, the ...
Obstructive sleep apnea affects nearly 54 million Americans, contributing to severe health complications like heart disease, stroke, and diabetes. Untreated OSA also imposes a staggering financial ...
Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This ...
Signifier Medical Technologies Limited ("Signifier"), a global leader in medical technology for sleep-disordered breathing, announced today that eXciteOSA, its non-invasive daytime therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results